nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Ifosfamide—testicular cancer	0.424	0.529	CiPCiCtD
Trabectedin—Alkylating Activity—Chlorambucil—testicular cancer	0.378	0.471	CiPCiCtD
Trabectedin—PTGS1—Ifosfamide—testicular cancer	0.0344	0.264	CbGbCtD
Trabectedin—CYP2C19—Ifosfamide—testicular cancer	0.0166	0.128	CbGbCtD
Trabectedin—PTGS1—Etoposide—testicular cancer	0.0164	0.126	CbGbCtD
Trabectedin—CYP2C9—Ifosfamide—testicular cancer	0.0138	0.106	CbGbCtD
Trabectedin—CYP2E1—Etoposide—testicular cancer	0.0127	0.0974	CbGbCtD
Trabectedin—CYP3A4—Ifosfamide—testicular cancer	0.00805	0.0617	CbGbCtD
Trabectedin—CYP2C9—Cisplatin—testicular cancer	0.00673	0.0516	CbGbCtD
Trabectedin—CYP2D6—Vinblastine—testicular cancer	0.00671	0.0515	CbGbCtD
Trabectedin—CYP3A4—Vinblastine—testicular cancer	0.00427	0.0328	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—testicular cancer	0.00413	0.0316	CbGbCtD
Trabectedin—CYP3A4—Etoposide—testicular cancer	0.00385	0.0295	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—testicular cancer	0.00262	0.0201	CbGbCtD
Trabectedin—Body temperature increased—Dactinomycin—testicular cancer	8.64e-05	0.00129	CcSEcCtD
Trabectedin—Abdominal pain—Dactinomycin—testicular cancer	8.64e-05	0.00129	CcSEcCtD
Trabectedin—Fatigue—Ifosfamide—testicular cancer	8.63e-05	0.00129	CcSEcCtD
Trabectedin—Oedema—Cisplatin—testicular cancer	8.63e-05	0.00129	CcSEcCtD
Trabectedin—Hypersensitivity—Bleomycin—testicular cancer	8.63e-05	0.00129	CcSEcCtD
Trabectedin—Infection—Cisplatin—testicular cancer	8.58e-05	0.00128	CcSEcCtD
Trabectedin—Constipation—Ifosfamide—testicular cancer	8.56e-05	0.00128	CcSEcCtD
Trabectedin—Loss of consciousness—Etoposide—testicular cancer	8.52e-05	0.00127	CcSEcCtD
Trabectedin—Nervous system disorder—Cisplatin—testicular cancer	8.47e-05	0.00126	CcSEcCtD
Trabectedin—Cough—Etoposide—testicular cancer	8.46e-05	0.00126	CcSEcCtD
Trabectedin—Thrombocytopenia—Cisplatin—testicular cancer	8.45e-05	0.00126	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—testicular cancer	8.45e-05	0.00126	CcSEcCtD
Trabectedin—Asthenia—Bleomycin—testicular cancer	8.41e-05	0.00125	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—testicular cancer	8.39e-05	0.00125	CcSEcCtD
Trabectedin—Skin disorder—Cisplatin—testicular cancer	8.39e-05	0.00125	CcSEcCtD
Trabectedin—Nausea—Vinblastine—testicular cancer	8.24e-05	0.00123	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—testicular cancer	8.24e-05	0.00123	CcSEcCtD
Trabectedin—Anorexia—Cisplatin—testicular cancer	8.23e-05	0.00123	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—testicular cancer	8.21e-05	0.00122	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	8.19e-05	0.00122	CcSEcCtD
Trabectedin—Gastrointestinal pain—Ifosfamide—testicular cancer	8.19e-05	0.00122	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—testicular cancer	8.12e-05	0.00121	CcSEcCtD
Trabectedin—Hypotension—Cisplatin—testicular cancer	8.07e-05	0.0012	CcSEcCtD
Trabectedin—Hypersensitivity—Dactinomycin—testicular cancer	8.05e-05	0.0012	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—testicular cancer	7.96e-05	0.00119	CcSEcCtD
Trabectedin—Abdominal pain—Ifosfamide—testicular cancer	7.92e-05	0.00118	CcSEcCtD
Trabectedin—Body temperature increased—Ifosfamide—testicular cancer	7.92e-05	0.00118	CcSEcCtD
Trabectedin—Pancytopenia—Methotrexate—testicular cancer	7.91e-05	0.00118	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Cisplatin—testicular cancer	7.87e-05	0.00117	CcSEcCtD
Trabectedin—Infection—Etoposide—testicular cancer	7.86e-05	0.00117	CcSEcCtD
Trabectedin—Asthenia—Dactinomycin—testicular cancer	7.84e-05	0.00117	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—testicular cancer	7.82e-05	0.00117	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—testicular cancer	7.79e-05	0.00116	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—testicular cancer	7.76e-05	0.00116	CcSEcCtD
Trabectedin—Paraesthesia—Cisplatin—testicular cancer	7.75e-05	0.00116	CcSEcCtD
Trabectedin—Thrombocytopenia—Etoposide—testicular cancer	7.74e-05	0.00116	CcSEcCtD
Trabectedin—Dyspnoea—Cisplatin—testicular cancer	7.7e-05	0.00115	CcSEcCtD
Trabectedin—Skin disorder—Etoposide—testicular cancer	7.68e-05	0.00115	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—testicular cancer	7.62e-05	0.00114	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—testicular cancer	7.6e-05	0.00113	CcSEcCtD
Trabectedin—Anorexia—Etoposide—testicular cancer	7.54e-05	0.00112	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	7.52e-05	0.00112	CcSEcCtD
Trabectedin—Decreased appetite—Cisplatin—testicular cancer	7.51e-05	0.00112	CcSEcCtD
Trabectedin—Diarrhoea—Dactinomycin—testicular cancer	7.48e-05	0.00112	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Cisplatin—testicular cancer	7.45e-05	0.00111	CcSEcCtD
Trabectedin—Vomiting—Bleomycin—testicular cancer	7.45e-05	0.00111	CcSEcCtD
Trabectedin—Infestation—Methotrexate—testicular cancer	7.43e-05	0.00111	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—testicular cancer	7.43e-05	0.00111	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—testicular cancer	7.4e-05	0.0011	CcSEcCtD
Trabectedin—Hypotension—Etoposide—testicular cancer	7.39e-05	0.0011	CcSEcCtD
Trabectedin—Rash—Bleomycin—testicular cancer	7.39e-05	0.0011	CcSEcCtD
Trabectedin—Dermatitis—Bleomycin—testicular cancer	7.38e-05	0.0011	CcSEcCtD
Trabectedin—Hypersensitivity—Ifosfamide—testicular cancer	7.38e-05	0.0011	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	7.36e-05	0.0011	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—testicular cancer	7.29e-05	0.00109	CcSEcCtD
Trabectedin—Stomatitis—Methotrexate—testicular cancer	7.24e-05	0.00108	CcSEcCtD
Trabectedin—Asthenia—Ifosfamide—testicular cancer	7.19e-05	0.00107	CcSEcCtD
Trabectedin—Paraesthesia—Etoposide—testicular cancer	7.1e-05	0.00106	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—testicular cancer	7.05e-05	0.00105	CcSEcCtD
Trabectedin—Dyspnoea—Etoposide—testicular cancer	7.05e-05	0.00105	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—testicular cancer	7.03e-05	0.00105	CcSEcCtD
Trabectedin—Nausea—Bleomycin—testicular cancer	6.96e-05	0.00104	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—testicular cancer	6.95e-05	0.00104	CcSEcCtD
Trabectedin—Infestation—Epirubicin—testicular cancer	6.95e-05	0.00104	CcSEcCtD
Trabectedin—Vomiting—Dactinomycin—testicular cancer	6.95e-05	0.00104	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—testicular cancer	6.93e-05	0.00103	CcSEcCtD
Trabectedin—Rash—Dactinomycin—testicular cancer	6.89e-05	0.00103	CcSEcCtD
Trabectedin—Decreased appetite—Etoposide—testicular cancer	6.88e-05	0.00103	CcSEcCtD
Trabectedin—Diarrhoea—Ifosfamide—testicular cancer	6.85e-05	0.00102	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—testicular cancer	6.85e-05	0.00102	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Etoposide—testicular cancer	6.83e-05	0.00102	CcSEcCtD
Trabectedin—Body temperature increased—Cisplatin—testicular cancer	6.83e-05	0.00102	CcSEcCtD
Trabectedin—Fatigue—Etoposide—testicular cancer	6.82e-05	0.00102	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—testicular cancer	6.78e-05	0.00101	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—testicular cancer	6.78e-05	0.00101	CcSEcCtD
Trabectedin—Constipation—Etoposide—testicular cancer	6.76e-05	0.00101	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—testicular cancer	6.75e-05	0.00101	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—testicular cancer	6.7e-05	0.001	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—testicular cancer	6.67e-05	0.000995	CcSEcCtD
Trabectedin—Dizziness—Ifosfamide—testicular cancer	6.62e-05	0.000988	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—testicular cancer	6.57e-05	0.000981	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—testicular cancer	6.53e-05	0.000974	CcSEcCtD
Trabectedin—Nausea—Dactinomycin—testicular cancer	6.49e-05	0.000968	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—testicular cancer	6.49e-05	0.000968	CcSEcCtD
Trabectedin—Gastrointestinal pain—Etoposide—testicular cancer	6.47e-05	0.000965	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—testicular cancer	6.43e-05	0.000959	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—testicular cancer	6.43e-05	0.000959	CcSEcCtD
Trabectedin—Vomiting—Ifosfamide—testicular cancer	6.37e-05	0.00095	CcSEcCtD
Trabectedin—Hypersensitivity—Cisplatin—testicular cancer	6.36e-05	0.000949	CcSEcCtD
Trabectedin—Rash—Ifosfamide—testicular cancer	6.31e-05	0.000942	CcSEcCtD
Trabectedin—Dermatitis—Ifosfamide—testicular cancer	6.31e-05	0.000941	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—testicular cancer	6.27e-05	0.000936	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—testicular cancer	6.27e-05	0.000935	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—testicular cancer	6.27e-05	0.000935	CcSEcCtD
Trabectedin—Abdominal pain—Etoposide—testicular cancer	6.25e-05	0.000933	CcSEcCtD
Trabectedin—Body temperature increased—Etoposide—testicular cancer	6.25e-05	0.000933	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—testicular cancer	6.24e-05	0.000931	CcSEcCtD
Trabectedin—Asthenia—Cisplatin—testicular cancer	6.19e-05	0.000924	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—testicular cancer	6.15e-05	0.000917	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—testicular cancer	6.13e-05	0.000915	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—testicular cancer	6.08e-05	0.000907	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—testicular cancer	6.05e-05	0.000902	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—testicular cancer	6.01e-05	0.000896	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—testicular cancer	6e-05	0.000895	CcSEcCtD
Trabectedin—Nausea—Ifosfamide—testicular cancer	5.95e-05	0.000887	CcSEcCtD
Trabectedin—Diarrhoea—Cisplatin—testicular cancer	5.91e-05	0.000881	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—testicular cancer	5.89e-05	0.000879	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—testicular cancer	5.84e-05	0.000871	CcSEcCtD
Trabectedin—Hypersensitivity—Etoposide—testicular cancer	5.83e-05	0.000869	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—testicular cancer	5.81e-05	0.000866	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—testicular cancer	5.8e-05	0.000866	CcSEcCtD
Trabectedin—Flushing—Epirubicin—testicular cancer	5.79e-05	0.000864	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—testicular cancer	5.77e-05	0.000861	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—testicular cancer	5.69e-05	0.000849	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—testicular cancer	5.68e-05	0.000848	CcSEcCtD
Trabectedin—Asthenia—Etoposide—testicular cancer	5.68e-05	0.000847	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—testicular cancer	5.67e-05	0.000846	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—testicular cancer	5.66e-05	0.000845	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—testicular cancer	5.62e-05	0.000839	CcSEcCtD
Trabectedin—Back pain—Methotrexate—testicular cancer	5.62e-05	0.000838	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—testicular cancer	5.51e-05	0.000823	CcSEcCtD
Trabectedin—Vomiting—Cisplatin—testicular cancer	5.49e-05	0.000819	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—testicular cancer	5.47e-05	0.000816	CcSEcCtD
Trabectedin—Rash—Cisplatin—testicular cancer	5.44e-05	0.000812	CcSEcCtD
Trabectedin—Dermatitis—Cisplatin—testicular cancer	5.44e-05	0.000811	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—testicular cancer	5.43e-05	0.00081	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—testicular cancer	5.41e-05	0.000807	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—testicular cancer	5.37e-05	0.0008	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—testicular cancer	5.36e-05	0.000799	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—testicular cancer	5.32e-05	0.000794	CcSEcCtD
Trabectedin—Back pain—Epirubicin—testicular cancer	5.26e-05	0.000784	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—testicular cancer	5.24e-05	0.000781	CcSEcCtD
Trabectedin—Dizziness—Etoposide—testicular cancer	5.23e-05	0.00078	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—testicular cancer	5.2e-05	0.000776	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—testicular cancer	5.2e-05	0.000775	CcSEcCtD
Trabectedin—Nausea—Cisplatin—testicular cancer	5.13e-05	0.000765	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—testicular cancer	5.1e-05	0.000761	CcSEcCtD
Trabectedin—Cough—Methotrexate—testicular cancer	5.07e-05	0.000756	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—testicular cancer	5.06e-05	0.000755	CcSEcCtD
Trabectedin—Vomiting—Etoposide—testicular cancer	5.03e-05	0.00075	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—testicular cancer	5.03e-05	0.00075	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—testicular cancer	5.02e-05	0.000749	CcSEcCtD
Trabectedin—Rash—Etoposide—testicular cancer	4.99e-05	0.000744	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—testicular cancer	4.98e-05	0.000743	CcSEcCtD
Trabectedin—Headache—Etoposide—testicular cancer	4.96e-05	0.000739	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—testicular cancer	4.94e-05	0.000737	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—testicular cancer	4.94e-05	0.000737	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—testicular cancer	4.92e-05	0.000734	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	4.91e-05	0.000732	CcSEcCtD
Trabectedin—Syncope—Epirubicin—testicular cancer	4.87e-05	0.000727	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—testicular cancer	4.86e-05	0.000725	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—testicular cancer	4.86e-05	0.000725	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—testicular cancer	4.77e-05	0.000712	CcSEcCtD
Trabectedin—Cough—Epirubicin—testicular cancer	4.74e-05	0.000707	CcSEcCtD
Trabectedin—Infection—Methotrexate—testicular cancer	4.71e-05	0.000702	CcSEcCtD
Trabectedin—Nausea—Etoposide—testicular cancer	4.7e-05	0.000701	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—testicular cancer	4.65e-05	0.000693	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—testicular cancer	4.65e-05	0.000693	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—testicular cancer	4.64e-05	0.000692	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—testicular cancer	4.63e-05	0.00069	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—testicular cancer	4.63e-05	0.00069	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—testicular cancer	4.6e-05	0.000686	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	4.59e-05	0.000685	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—testicular cancer	4.52e-05	0.000674	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—testicular cancer	4.51e-05	0.000672	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—testicular cancer	4.5e-05	0.000671	CcSEcCtD
Trabectedin—Oedema—Epirubicin—testicular cancer	4.43e-05	0.000661	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—testicular cancer	4.43e-05	0.00066	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—testicular cancer	4.42e-05	0.000659	CcSEcCtD
Trabectedin—Infection—Epirubicin—testicular cancer	4.4e-05	0.000657	CcSEcCtD
Trabectedin—Cough—Doxorubicin—testicular cancer	4.39e-05	0.000654	CcSEcCtD
Trabectedin—Shock—Epirubicin—testicular cancer	4.36e-05	0.000651	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—testicular cancer	4.35e-05	0.000649	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—testicular cancer	4.34e-05	0.000648	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—testicular cancer	4.32e-05	0.000644	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—testicular cancer	4.31e-05	0.000642	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—testicular cancer	4.29e-05	0.000639	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—testicular cancer	4.28e-05	0.000638	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—testicular cancer	4.28e-05	0.000638	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—testicular cancer	4.25e-05	0.000635	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	4.25e-05	0.000634	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—testicular cancer	4.23e-05	0.00063	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—testicular cancer	4.22e-05	0.00063	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—testicular cancer	4.17e-05	0.000622	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—testicular cancer	4.14e-05	0.000618	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—testicular cancer	4.12e-05	0.000614	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—testicular cancer	4.1e-05	0.000612	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—testicular cancer	4.09e-05	0.00061	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—testicular cancer	4.08e-05	0.000609	CcSEcCtD
Trabectedin—Infection—Doxorubicin—testicular cancer	4.08e-05	0.000608	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—testicular cancer	4.04e-05	0.000603	CcSEcCtD
Trabectedin—Shock—Doxorubicin—testicular cancer	4.04e-05	0.000602	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—testicular cancer	4.02e-05	0.0006	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—testicular cancer	4.02e-05	0.000599	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—testicular cancer	4.01e-05	0.000598	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—testicular cancer	3.98e-05	0.000594	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—testicular cancer	3.98e-05	0.000594	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—testicular cancer	3.95e-05	0.00059	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—testicular cancer	3.91e-05	0.000583	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—testicular cancer	3.9e-05	0.000582	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—testicular cancer	3.87e-05	0.000578	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—testicular cancer	3.85e-05	0.000575	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—testicular cancer	3.83e-05	0.000572	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—testicular cancer	3.83e-05	0.000571	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—testicular cancer	3.82e-05	0.00057	CcSEcCtD
Trabectedin—Constipation—Epirubicin—testicular cancer	3.79e-05	0.000566	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—testicular cancer	3.75e-05	0.000559	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—testicular cancer	3.75e-05	0.000559	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	3.74e-05	0.000558	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—testicular cancer	3.71e-05	0.000553	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—testicular cancer	3.68e-05	0.000549	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—testicular cancer	3.66e-05	0.000546	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—testicular cancer	3.63e-05	0.000541	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—testicular cancer	3.61e-05	0.000539	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—testicular cancer	3.57e-05	0.000532	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—testicular cancer	3.54e-05	0.000528	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—testicular cancer	3.54e-05	0.000528	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—testicular cancer	3.51e-05	0.000523	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—testicular cancer	3.51e-05	0.000523	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—testicular cancer	3.51e-05	0.000523	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—testicular cancer	3.49e-05	0.000521	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—testicular cancer	3.4e-05	0.000507	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—testicular cancer	3.35e-05	0.0005	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—testicular cancer	3.27e-05	0.000487	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—testicular cancer	3.24e-05	0.000484	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—testicular cancer	3.24e-05	0.000484	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—testicular cancer	3.24e-05	0.000484	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—testicular cancer	3.18e-05	0.000475	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—testicular cancer	3.13e-05	0.000467	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—testicular cancer	3.03e-05	0.000453	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—testicular cancer	3.02e-05	0.000451	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—testicular cancer	3.01e-05	0.000449	CcSEcCtD
Trabectedin—Rash—Methotrexate—testicular cancer	2.99e-05	0.000446	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—testicular cancer	2.98e-05	0.000445	CcSEcCtD
Trabectedin—Headache—Methotrexate—testicular cancer	2.97e-05	0.000443	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—testicular cancer	2.94e-05	0.000439	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—testicular cancer	2.93e-05	0.000437	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—testicular cancer	2.82e-05	0.000421	CcSEcCtD
Trabectedin—Nausea—Methotrexate—testicular cancer	2.81e-05	0.00042	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—testicular cancer	2.81e-05	0.000419	CcSEcCtD
Trabectedin—Rash—Epirubicin—testicular cancer	2.8e-05	0.000417	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—testicular cancer	2.79e-05	0.000417	CcSEcCtD
Trabectedin—Headache—Epirubicin—testicular cancer	2.78e-05	0.000414	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—testicular cancer	2.71e-05	0.000405	CcSEcCtD
Trabectedin—Nausea—Epirubicin—testicular cancer	2.63e-05	0.000393	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—testicular cancer	2.61e-05	0.000389	CcSEcCtD
Trabectedin—Rash—Doxorubicin—testicular cancer	2.59e-05	0.000386	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—testicular cancer	2.58e-05	0.000385	CcSEcCtD
Trabectedin—Headache—Doxorubicin—testicular cancer	2.57e-05	0.000383	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—testicular cancer	2.44e-05	0.000363	CcSEcCtD
